Murphy Oil upgraded to Overweight at Piper Sandler, noting superior operating leverage and a potential catalyst from the Hai ...
A number of stocks fell in the afternoon session after investors raised concerns over the stability of the private credit market, following a key announcement from a major bank.
Piper Sandler upgraded Occidental Petroleum and Murphy Oil to Overweight from Neutral after raising its mid-cycle oil price forecast, citing tighter expected crude balances and potential supply ...
Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.
21hon MSN
Piper Sandler Sees Path to Growth for Bristol-Myers Squibb Company (BMY) After Eliquis Patent Expiry
Bristol-Myers Squibb Company (NYSE:BMY) ranks among the 14 safe stocks to buy now for a starter stock portfolio. On February 23, Piper Sandler boosted its price target for Bristol-Myers Squibb Company ...
TechnipFMC (NYSE: FTI) announced today that Doug Pferdehirt, Chair and Chief Executive Officer, will speak at the Piper Sandler 26th Annual Energy Conference on Tuesday, March 17, 2026, at 10:00 a.m.
Phillips 66 (NYSE: PSX) executives will participate in a fireside chat at the Piper Sandler 26th Annual Energy Conference at 1:30 p.m. ET on Tuesday, March 17, 2026. Participants will include Kevin ...
ImmunityBio, Inc. (NASDAQ:IBRX) is among the 12 Best Performing Stocks in February. On March 4, 2026, Piper Sandler analyst Patrick Soon-Shiong increased ImmunityBio, Inc. (NASDAQ:IBRX)’s price ...
Piper Sandler upgrades CrowdStrike (CRWD) to Overweight with a $520 target, citing AI as an opportunity and M&A tailwinds—get the stock outlook now.
Fintel on MSN
Piper Sandler upgrades Karman Holdings (KRMN)
Fintel reports that on March 6, 2026, Piper Sandler upgraded their outlook for Karman Holdings (NYSE:KRMN) from Neutral to ...
Detailed price information for Compass Therapeutics Inc (CMPX-Q) from The Globe and Mail including charting and trades.
Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 19, Travere Therapeutics Inc. (NASDAQ:TVTX) released the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results